迈瑞医疗
(300760)
| 流通市值：1953.04亿 | | | 总市值：1954.88亿 |
| 流通股本：12.11亿 | | | 总股本：12.12亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 17,746,969,604 | 8,352,015,912 | 33,282,159,404 | 25,833,906,543 |
| 营业收入 | 17,746,969,604 | 8,352,015,912 | 33,282,159,404 | 25,833,906,543 |
| 二、营业总成本 | 12,313,659,385 | 5,905,265,678 | 23,608,910,747 | 17,055,866,071 |
| 营业成本 | 6,950,862,309 | 3,184,616,660 | 13,207,838,172 | 9,829,018,551 |
| 税金及附加 | 197,717,792 | 94,353,056 | 389,477,342 | 302,964,242 |
| 销售费用 | 2,516,220,938 | 1,239,689,610 | 5,145,135,431 | 3,735,210,386 |
| 管理费用 | 696,325,373 | 343,826,411 | 1,550,675,756 | 1,046,880,948 |
| 研发费用 | 1,569,511,152 | 801,738,588 | 3,578,692,207 | 2,434,870,090 |
| 财务费用 | 383,021,821 | 241,041,353 | -262,908,161 | -293,078,146 |
| 其中:利息费用 | 11,993,086 | 6,070,916 | 24,024,138 | 16,751,412 |
| 其中:利息收入 | 246,018,611 | 114,163,421 | 479,906,226 | 358,085,286 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 587,825 | 1,007,831 | 485,746 | 669,858 |
| 加:投资收益 | 19,984,846 | 10,229,985 | 114,953,316 | 111,310,332 |
| 资产处置收益 | -9,022,964 | -7,089,989 | 10,715,933 | 9,892,876 |
| 资产减值损失(新) | -67,535,273 | -20,814,987 | -335,842,079 | -203,062,364 |
| 信用减值损失(新) | -5,251,257 | -9,522,134 | -196,027,800 | -156,211,934 |
| 其他收益 | 194,188,774 | 103,850,398 | 527,360,218 | 406,772,773 |
| 四、营业利润 | 5,566,262,170 | 2,524,411,338 | 9,794,893,991 | 8,947,412,013 |
| 加:营业外收入 | 30,783,463 | 24,549,320 | 34,428,279 | 18,911,609 |
| 减:营业外支出 | 40,951,927 | 7,612,978 | 155,356,531 | 64,711,790 |
| 五、利润总额 | 5,556,093,706 | 2,541,347,680 | 9,673,965,739 | 8,901,611,832 |
| 减:所得税费用 | 509,187,626 | 114,809,554 | 1,222,494,334 | 1,087,718,256 |
| 六、净利润 | 5,046,906,080 | 2,426,538,126 | 8,451,471,405 | 7,813,893,576 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 5,046,906,080 | 2,426,538,126 | 8,451,471,405 | 7,813,893,576 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 4,796,791,800 | 2,329,658,005 | 8,135,775,409 | 7,570,044,518 |
| 少数股东损益 | 250,114,280 | 96,880,121 | 315,695,996 | 243,849,058 |
| 扣除非经常损益后的净利润 | 4,784,797,726 | 2,296,470,040 | 8,068,550,808 | 7,462,681,541 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 3.96 | 1.92 | 6.71 | 6.25 |
| (二)稀释每股收益 | 3.96 | 1.92 | 6.71 | 6.25 |
| 八、其他综合收益 | -363,071,595 | -243,472,238 | 278,427,564 | 399,264,979 |
| 归属于母公司股东的其他综合收益 | -353,176,330 | -236,962,743 | 254,979,713 | 368,192,867 |
| 九、综合收益总额 | 4,683,834,485 | 2,183,065,888 | 8,729,898,969 | 8,213,158,555 |
| 归属于母公司股东的综合收益总额 | 4,443,615,470 | 2,092,695,262 | 8,390,755,122 | 7,938,237,385 |
| 归属于少数股东的综合收益总额 | 240,219,015 | 90,370,626 | 339,143,847 | 274,921,170 |
| 公告日期 | 2026-08-29 | 2026-04-29 | 2026-03-31 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |